Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Medtech4Health Phase 3, 2022-2024

Reference number
Coordinator Sweden Medtech4Health AB (svb)
Funding from Vinnova SEK 12 882 330
Project duration October 2022 - June 2025
Status Ongoing

Purpose and goal

** Denna text är maskinöversatt ** The aim is to make healthcare more efficient through innovations and create sustainable conditions for innovative and viable medical technology research and industry, nationally and internationally. The overall vision aims to create a better life for the patient/individual/citizen in Sweden. Medtech4Health shall strengthen the conditions for medical technology innovations from academic research and small and medium-sized companies to be able to develop and market new medical technology.

Expected effects and result

** Denna text är maskinöversatt ** Expected long-term effects of the program are, among other things, increased awareness and knowledge in health, care and care about the benefits of medical technology, more sustainable medical technology innovations made useful in health care, increased competitiveness of medical technology companies operating in Sweden and more Swedish SMEs that stay and grow in the Swedish market.

Planned approach and implementation

** Denna text är maskinöversatt ** The business will mainly be conducted through two legs; strategic and systemic development projects as well as open calls for tenders where the development projects aim to either work with knowledge transfer or the reduction of obstacles to meeting the goals. The program works with regional healthcare areas and national actors as well as a national program office. the main work takes place inside the different projects.

External links

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 14 January 2025

Reference number 2022-01019